The company said full-year net sales rose 3.6% to $15.4 billion, and rose 3.9% on a constant currency basis. Adjusted diluted EPS rose 7.8% on a constant currency basis to $1.92.

1. 01

   The company said full-year net sales rose 3.6% to $15.4 billion, and rose 3.9% on a constant currency basis. Adjusted diluted EPS rose 7.8% on a constant currency basis to $1.92.

2. 02

   Keurig Dr Pepper said full-year GAAP operating income fell 18.8% to $2.6 billion. It cited the decline as driven mainly by goodwill and other intangible asset impairments of $718 million and an accrual of $225 million for upcoming GHOST-related distribution termination payments.

3. 03

   The company said full-year operating cash flow rose 67.0% to $2.2 billion, and free cash flow rose 81.8% to $1.7 billion.

4. 04

   The company said it expects net sales to grow at a mid-single-digit rate and Adjusted diluted EPS to grow at a high-single-digit rate on a constant currency basis in 2025, including the expected contribution from the GHOST acquisition. It also said that, at current rates, foreign currency translation is expected to be a one to two percentage point headwind to full-year sales and earnings growth.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.